Eli Lilly and Company (LLY) and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation  
7/30/2009 9:27:21 AM

TAINAN, Taiwan, July 30 /PRNewswire-Asia/ -- Eli Lilly & Company ("Lilly") and ScinoPharm Taiwan Ltd. ("ScinoPharm") announced today that they have reached an amicable resolution of all ongoing patent litigations between the companies relating to ScinoPharm's manufacture and sale of gemcitabine hydrochloride around the world.